PRLDPRELUDE THERAPEUTICS INC
CUSIP 74065P101 · common stock
2 tracked investors held PRELUDE THERAPEUTICS INC (PRLD) at the end of Q3 2026, worth $64.9M in total. The largest holder was Julian Baker, with 0.2% of its portfolio. Adar1 Capital Management sold out of its position this quarter.
Holders · Q3 2026
2
New holders
0
Value held
$64.9M
Quarter-end price (est.)
$3.91
Investors holding PRLD · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Julian Baker Baker Bros. Advisors LP | 0.19% | 10,123,824 | $39.6M | HOLD |
| RA Capital Management RA Capital Management, L.P. | 0.25% | 6,475,882 | $25.3M | HOLD |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Adar1 Capital Management | 0.22% | 900,900 | $4.8M | EXIT |